Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$27.2M in Q3 2026 · $527K over twelve months
Operating cash flow$31.9M
Capital spending−$4.7M
Free cash flow+$27.2M
Cash / net income4.6×
Cash conversion cycle24 days
Analysis
In Q3 2026, MGP Ingredients generated $31.9M of operating cash flow and spent $4.7M on capital projects, leaving free cash flow of $27.2M. That is $361K less than in Q3 2025 ($27.6M).
Over the twelve months to Sep 30, 2026, operating cash flow was $20.2M; the largest uses were other financing ($62.1M), capital spending ($19.7M), dividends ($10.4M); besides operations, cash came from net borrowing (+) / repaid (−) ($71.6M), other investing ($1.6M); the cash balance rose by $154K.
Operating cash flow was $31.9M against net income of $6.9M — 4.6× profit, cash ran ahead of reported earnings. The largest differences: receivables +$9.0M, inventory +$7.4M, depreciation & amortization +$6.4M.
Its cash conversion cycle was 24 days (receivables 77 + inventory 0 − payables 54).
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $31.9M, Capital spending $4.7M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $485M; the largest uses were capital spending ($265M) and acquisitions ($253M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$13.6M
Debt$341M
Net debt$328M
Due within a year$6.4M
MGP Ingredients funds itself: free cash flow was $527K over the last twelve months, and $13.6M of cash and investments stands against $341M of debt ($6.4M due within a year, 2.1× covered by cash).
Principal due in each year as disclosed in the annual report, against $13.6M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
77
—
54
24
Q2 2026
70
—
57
13
Q1 2026
86
—
64
21
Q4 2025
74
—
50
24
Q3 2025
79
—
48
31
Q2 2025
70
—
50
20
Q1 2025
95
—
69
25
Q4 2024
71
—
52
19
Every quarter
Quarter
Operating cash flow
Capital spending
Buybacks
Dividends
Net borrowing (+) / repaid (−)
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$31.9M
−$4.7M
−$35K
−$2.6M
−$28.6M
$4.2M
$27.2M
Q2 2026
−$47.7M
−$4.5M
—
−$2.6M
$124M
−$7.4M
−$52.2M
Q1 2026
$7.0M
−$5.7M
−$886K
−$2.6M
−$7.6M
$8.1M
$1.2M
Q4 2025
$29.1M
−$4.8M
—
−$2.6M
−$16.6M
−$5.0M
$24.3M
Q3 2025
$36.1M
−$8.5M
—
−$2.6M
−$28.6M
$3.9M
$27.6M
Q2 2025
$11.7M
−$12.2M
—
−$2.6M
—
$2.8M
−$557K
Q1 2025
$44.7M
−$19.9M
−$1.0M
−$2.6M
−$26.6M
$5.2M
$24.8M
Q4 2024
$28.8M
−$18.3M
−$36.5M
−$2.6M
$33.4M
−$4.5M
$10.4M
MGP Ingredients: income statement and cash flow
MGP Ingredients, Q3 2026: revenue $118M (-10% year over year), operating margin 10.2%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.